Ipca Laboratories Limited
NSE:IPCALAB.NS
1558.65 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 77,050.4 | 62,443.2 | 57,664.6 | 53,409.5 | 45,587 | 36,921.9 | 32,065.9 | 31,493.6 | 28,453.3 | 31,166 | 32,469.9 | 27,737.7 | 23,587.3 | 18,825.4 | 15,595.5 | 12,838 | 10,510.4 | 9,391.1 | 7,557.019 | 6,790.316 |
| Cost of Revenue
| 46,414.2 | 23,065.1 | 21,059.7 | 18,017.6 | 17,088.4 | 12,903.8 | 11,762.1 | 11,641.2 | 11,097.4 | 12,099.1 | 11,849.4 | 11,460 | 9,131.2 | 7,764.2 | 6,456 | 5,072.7 | 4,638.8 | 4,012.8 | 5,438.904 | 4,743.507 |
| Gross Profit
| 30,636.2 | 39,378.1 | 36,604.9 | 35,391.9 | 28,498.6 | 24,018.1 | 20,303.8 | 19,852.4 | 17,355.9 | 19,066.9 | 20,620.5 | 16,277.7 | 14,456.1 | 11,061.2 | 9,139.5 | 7,765.3 | 5,871.6 | 5,378.3 | 2,118.115 | 2,046.809 |
| Gross Profit Ratio
| 0.398 | 0.631 | 0.635 | 0.663 | 0.625 | 0.651 | 0.633 | 0.63 | 0.61 | 0.612 | 0.635 | 0.587 | 0.613 | 0.588 | 0.586 | 0.605 | 0.559 | 0.573 | 0.28 | 0.301 |
| Reseach & Development Expenses
| 1,707.1 | 461.3 | 418 | 523.8 | 313.8 | 207.4 | 266.2 | 416.8 | 404.6 | 402.6 | 624.7 | 355.4 | 404.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,174 | 761.9 | 736.5 | 970.7 | 585.8 | 799.4 | 808.1 | 578.4 | 487.9 | 485.5 | 391.5 | 350.2 | 2,592.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 7,086.3 | 5,561.7 | 3,696.8 | 2,988.6 | 3,315.6 | 2,940.6 | 2,525.6 | 2,597.1 | 2,137.8 | 2,450 | 2,311.8 | 2,129.4 | 1,960.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 22,253.2 | 6,323.6 | 4,433.3 | 3,959.3 | 3,901.4 | 3,740 | 3,333.7 | 3,175.5 | 2,625.7 | 2,935.5 | 2,703.3 | 2,479.6 | 4,553.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 1,247.7 | 1,256.2 | 155.7 | 144.8 | 201.9 | 210.7 | 191.5 | 24.2 | 16.2 | 28.4 | 36 | 23.3 | 11.8 | 7,340.3 | 6,183.7 | 6,264.1 | 3,915.1 | 3,610.5 | 1,239.386 | 1,040.862 |
| Operating Expenses
| 22,253.2 | 32,726 | 25,978.3 | 22,186.8 | 21,051.9 | 18,667.5 | 17,467.9 | 17,196.6 | 15,575.8 | 15,372.4 | 13,474.6 | 10,857.3 | 9,934.2 | 7,340.3 | 6,183.7 | 6,264.1 | 3,915.1 | 3,610.5 | 1,239.386 | 1,040.862 |
| Operating Income
| 8,383 | 7,033.5 | 10,590.6 | 13,145.9 | 7,421.1 | 5,314.5 | 2,835.9 | 2,655.8 | 1,780.1 | 3,694.5 | 7,145.9 | 5,420.4 | 4,521.9 | 3,720.9 | 2,955.8 | 1,501.2 | 1,956.5 | 1,767.8 | 878.729 | 1,005.947 |
| Operating Income Ratio
| 0.109 | 0.113 | 0.184 | 0.246 | 0.163 | 0.144 | 0.088 | 0.084 | 0.063 | 0.119 | 0.22 | 0.195 | 0.192 | 0.198 | 0.19 | 0.117 | 0.186 | 0.188 | 0.116 | 0.148 |
| Total Other Income Expenses Net
| 43.7 | 290 | 555 | 666.9 | -32.2 | 150.1 | 69.4 | 47.4 | -627.1 | -83.7 | -840 | -877.7 | -878.8 | -314 | -293.2 | -318 | -203.9 | -224.7 | -133.726 | -64.814 |
| Income Before Tax
| 8,426.7 | 7,452.9 | 11,357.2 | 13,812.8 | 7,388.9 | 5,464.6 | 2,905.3 | 2,703.2 | 1,153 | 3,610.8 | 6,305.9 | 4,542.7 | 3,643.1 | 3,406.9 | 2,662.6 | 1,183.2 | 1,752.6 | 1,543.1 | 745.003 | 941.133 |
| Income Before Tax Ratio
| 0.109 | 0.119 | 0.197 | 0.259 | 0.162 | 0.148 | 0.091 | 0.086 | 0.041 | 0.116 | 0.194 | 0.164 | 0.154 | 0.181 | 0.171 | 0.092 | 0.167 | 0.164 | 0.099 | 0.139 |
| Income Tax Expense
| 3,134.6 | 2,533.6 | 2,247.7 | 2,401.4 | 1,353.3 | 1,042.4 | 511.1 | 675.2 | 185.7 | 1,019.3 | 1,523.9 | 1,299.4 | 881.1 | 783.8 | 627.2 | 232.5 | 357.9 | 293.8 | 144.772 | 238.258 |
| Net Income
| 5,473.5 | 4,713.2 | 8,840.8 | 11,400.1 | 6,063.2 | 4,448.3 | 2,394.2 | 2,028 | 967.3 | 2,591.5 | 4,782 | 3,243.3 | 2,770.6 | 2,628.2 | 2,053.6 | 1,008 | 1,359.3 | 1,261.7 | 615.046 | 740.85 |
| Net Income Ratio
| 0.071 | 0.075 | 0.153 | 0.213 | 0.133 | 0.12 | 0.075 | 0.064 | 0.034 | 0.083 | 0.147 | 0.117 | 0.117 | 0.14 | 0.132 | 0.079 | 0.129 | 0.134 | 0.081 | 0.109 |
| EPS
| 21.57 | 18.58 | 34.85 | 45.01 | 24 | 17.61 | 9.49 | 7.71 | 3.69 | 10.07 | 18.96 | 12.83 | 10.99 | 10.48 | 8.22 | 4.01 | 5.43 | 5.05 | 2.46 | 2.96 |
| EPS Diluted
| 21.57 | 18.58 | 34.85 | 45.01 | 23.98 | 17.61 | 9.49 | 7.71 | 3.69 | 10.07 | 18.96 | 12.83 | 10.99 | 10.48 | 8.21 | 4 | 5.41 | 5.03 | 2.46 | 2.96 |
| EBITDA
| 11,955.4 | 10,523.9 | 13,716.5 | 16,085.6 | 9,808.6 | 7,416.1 | 4,877.1 | 4,646.1 | 3,120.8 | 5,662 | 7,538.8 | 5,688.5 | 5,276.3 | 4,278.8 | 3,452.6 | 1,897.8 | 2,281.6 | 2,046.7 | 1,123.328 | 1,214.334 |
| EBITDA Ratio
| 0.155 | 0.169 | 0.238 | 0.301 | 0.215 | 0.201 | 0.152 | 0.148 | 0.11 | 0.182 | 0.232 | 0.205 | 0.224 | 0.227 | 0.221 | 0.148 | 0.217 | 0.218 | 0.149 | 0.179 |